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Objectives. This study sought to evaluate the in-hospital and 
postdischarge mortality of patients with an acute myocardial 
infarction in the 1990s. 
Background. The widespread implementation of therapeutic 
interventions that modify the natural history of coronary artery 
disease has led to changes in the profile and survival of patients 
with an acute myocardial infarction. Although data exist for 
selected subsets of patients with an acute myocardial infarction, at 
this time there is little recent prospective information on all 
patients presenting with an acute myocardial infarction, particu- 
larly for survival after hospital discharge. 
Methods. All patients _<75 years old presenting with an acute 
myocardial infarction between July 1, 1990 and June 30, 1992 at 
nine Canadian hospitals were prospectively evaluated and fol- 
lowed up for 1 year. From November 1991, patients of all ages 
were included. In two centers, recruitment continued until Decem- 
ber 31, 1992. A total of 3,178 patients were recruited. 
Results. The in-hospital mortality rote of patients <75 years 
old was 8.4%, and that at 1 year after hospital discharge was 5.3%. 
For patients of all ages recruited after November 1, 1991, the 
in-hospital mortality rate was 9.9% and 7.1% for 1 year after 
hospital discharge. For patients <75 years old, age carried an 
independent in.hospital but no postdischarge risk. Female pa- 
tients had a twofold greater risk of dying in hospital. After 
hospital discharge, only 1.7% of patients <75 years old and 1.9% 
of patients of all ages died of a presumed arrhythmic death. 
Premature ventricular contractions had no independent prognos- 
tic value. The relatively low in-hospital (5.3%) and postdischarge 
(6.1%) reinfarction rate may have contributed to improved sur- 
vival. A greater reinfarction rate in patients > 75 years old (17.4% 
vs. 9.6%, p < 0.001) may have contributed to their poorer 
outcome. 
Conclusions. One-year mortality after acute myocardial infarc- 
tion continues to decrease, and changes in the prognostic value of 
traditional methods of risk stratification have occurred. 
(JAm CoU Cardio11996;27:1119-27) 
Over the past 30 years, numerous interventions designed to 
decrease the in-hospital and postdischarge mortality of pa- 
tients with an acute myocardial infarction have been identified 
and implemented (1-9). In addition, changes in life-style (10), 
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in the treatment ofcoronary artery disease risk factors (11,12) 
and in the treatment ofchronic oronary artery disease have 
occurred that may influence peri-infarction survival and char- 
acteristics. However, the exact net benefit of the cumulative 
effect of these changes on the survival of the overall patient 
population having an acute myocardial infarction remains 
elusive. Although recent studies have documented a trend 
toward a decrease in mortality, they generally have not been 
designed to address this question, have been either elatively 
small, were exclusive to certain categories ofpatients, uffered 
from lack of rigorous diagnostic criteria or were retrospective, 
thus limiting our ability to extrapolate their results to the 
general patient population. This is particularly true for mor- 
tality after hospital discharge, where in the thrombolytic era, 
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no study of a large cohort that includes all patients having an 
acute myocardial infarction is available. Recent studies have 
also suggested that in-hospital (9,13) and postdischarge (13) 
reinfarction rates have decreased. However, as with recent 
mortality studies, they have generally been limited to selected 
patient groups, in contrast o the present all-inclusive cohort 
study of patients having an acute myocardial infarction during 
the recent hrombolytic era. 
The extent to which changes in lifestyle and therapeutic 
interventions have modified the profile of patients having an 
acute myocardial infarction and modified our ability to identify 
high-risk patients by the use of traditional means (14), such as 
left ventricular ejection fraction or the frequency of premature 
ventricular contractions, i  also uncertain. The low mortality in 
the placebo group of the Cardiac Arrhythmia Suppression 
Trial (CAST) (15) and other recent studies underscores the 
need for such a reevaluation of postinfarction risk stratifica- 
tion. 
The Canadian Assessment of Myocardial Infarction 
(CAMI) study was undertaken to obtain more recent informa- 
tion on these important infarct-related subjects in an all 
inclusive study of all patients having an acute myocardial 
infarction in nine hospitals across Canada. The inclusion of all 
patients having a myocardial infarction with a minimal 
follow-up of 1 year with ascertainment of vital status in 
>99.9% of patients provided the ability to assess risk profile in 
a representative sample of the general myocardial infarction 
population. 
Methods 
Four thousand one hundred thirty-three patients ustaining 
an acute myocardial infarction in nine hospital centers (eight 
university- and one community-based) between July 1, 1990 
and June 30, 1992 were documented in a prospective manner. 
In three of these centers, two university- and one community- 
based, recruitment continued until December 31, 1992. Seven 
of the eight university hospitals had facilities for cardiac 
catheterization a d cardiac surgery. The community hospital 
had neither facility. Patients were identified by reviewing all 
daily hospital admissions to the coronary care or intensive care 
units or to the cardiology division. In addition, the cardiologists 
covering the coronary care unit, the ward and the consultation 
service were questioned three times weekly for identification of 
other potential patients having had an acute myocardial infarc- 
tion but hospitalized on the ward or elsewhere in the hospital. 
Finally, all deaths in the emergency room were also reviewed, 
and patients meeting the study criteria for an acute myocardial 
infarction were included in the study. The study design was 
reviewed and approved by the institutional review boards of 
the various centers. 
An acute myocardial infarction was defined as at least two 
of the following: 1) chest pain lasting at least 20 rain, 2) new Q 
wave of at least 0.04 s in at least two contiguous leads, or 
3) creatine klnase (CK) ->1.5 times the upper limit of normal 
or CK-MB fraction >5% when simultaneous reference CK 
exceeded the upper limit of normal. A patient with probable 
acute myocardial infarction was defined as one who died within 
4 h after having at least 20 min of chest pain and continuous ST 
segment elevation in two contiguous leads but who did not 
meet the criteria for an acute myocardial infarction. For the 
purposes of this report, definite and probable myocardial 
infarctions were considered together. 
From July 1, 1990 to October 31, 1991, the only exclusion 
criterion was age >75 years. During that time period, 2,477 
patients were recruited. Thereafter, 1,656 patients of all ages 
were included, and there were no exclusion criteria. All 
patients had demographic variables and cardiac history as- 
sessed. In addition, the characteristics of and the therapeutic 
interventions used to treat their acute myocardial infarction 
were documented. Data were collected by specialized research 
nurses and verified by the participating physicians. Information 
was obtained by chart review, by direct interview with the 
patient and his or her family and by interviewing the treating 
physician. For end points, all data pertinent to the event were 
verified. Of these consecutive patients with an acute myocar- 
dial infarction, 3,178 had presented irectly to or had their 
myocardial infarction in the participating hospitals, and 955 
had been transferred from another institution. This report 
includes only those having presented irectly to or having had 
their myocardial infarction in the participating hospitals. Com- 
plete data were obtained in all but 45 of these patients, 25 of 
whom died within the first few hours of their infarction and 
thus could not be questioned regarding their prior medical 
history. In the other 20 patients, information regarding past 
medical history could not be verified to the investigators' and 
nurses' satisfaction. No assumptions were made regarding 
missing data. 
Of the 3,178 patients presenting directly to the participating 
hospitals, 316 died in hospital, and 2,862 were discharged. 
Patients surviving 5 days were asked to agree to a more 
complete valuation, which included assessment of left ventric- 
ular ejection fraction and 24-h Holter monitoring before 
hospital discharge and follow-up visits at 6 and 12 months. Two 
thousand one hundred ninety-two (77%) of these surviving 
patients agreed to the more complete valuation and follow- 
up, whereas the other 670 (23%) had an evaluation of vital 
status only. Of the 670 patients followed up only for vital 
status, 69 were excluded from more complete valuation and 
follow-up because of severe instability or an associated termi- 
nal disease, 70 were excluded because of geographic reasons 
(could not come to follow-up visits), 319 because of patient 
refusal, 33 for psychological or social reasons, and 179 for 
logistic reasons. Of patients having a more complete follow-up, 
1,823 (83%) had left ventricular ejection fraction assessed. In
the other 17%, this measurement was considered inadequate 
or was not done because of reticence of the treating physician. 
Left ventricular ejection fraction was obtained by radionuclide 
angiography in 1,350 patients, by contrast angiography in 388 
patients and by echocardiography in 85 patients. One thousand 
six hundred fourteen patients (74%) had at least 18 h of 
analyzable Holter monitoring. 
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Follow-up. On December 31, 1993, all patients had been 
followed up for at least 12 months. The vital status of all but 
three patients could be established. The details concerning the 
death of all 487 patients (in or out of hospital, complete 
follow-up or vital status only) were ascertained, and deaths 
classified by an independent mortality committee according to 
a predefined classification. Deaths were classified first accord- 
ing to whether they were cardiovascular o not. Cardiovascular 
deaths were then subclassified into 1) recurrent myocardial 
infarction (definite if they met the entrance criteria or if 
autopsy proven or probable if they met the probable myocar- 
dial infarction criteria) if patient died within the same hospital 
admission or within 7 days of the recurrent infarction; 2) low 
output, defined as death in a patient with severe New York 
Heart Association functional class IV heart failure or shock 
with a least two of the following three: evidence of poor 
perfusion, systolic blood pressure <90 mm Hg or refractory 
congestive symptoms; 3) arrhythmic death (definite or pre- 
sumed according to the CAST criteria) (15); 4) procedural; or 
5) other cardiovascular, which included eaths resulting from 
cardiovascular p ocedures, troke, aneurysms, pulmonary em- 
boll, cardiac rupture, peripheral or renovascular disease or 
other cardiovascular-related deaths. 
Recurrent myocardial infarction. All patients were evalu- 
ated for recurrent myocardial infarction during their hospital 
stay. Recurrent myocardial infarction, if nonfatal, had to meet 
the same entry criteria as the study itself except that if it 
occurred before normalization of CK levels of the index 
myocardial infarction, a 20% rise in CK or CK-MB fraction 
was considered significant, and, if fatal, had to meet he criteria 
of the mortality committee. Recurrent myocardial infarction 
by definition had to occur >24 h after the onset of the index 
myocardial infarction. The 1-year postdischarge r infarction 
rate was ascertained in only the 2,192 patients who agreed to 
the more complete follow-up. 
Review of previous postinfarction studies. Studies of in- 
hospital (16-32) and postdischarge (14,18,19,27,32-34) mor- 
tality from 1966 to the present were evaluated, and studies with 
the fewest exclusion criteria were chosen and are presented in
Figures 1 and 2. Because of the inevitable selection bias 
associated with studies evaluating thrombolytic use, these types 
of studies were not considered in our analyses. Important 
exclusion criteria are provided for all studies in the legends to 
Figures 1 and 2. As in this study (CAMI), patients >75 years 
old were excluded for the first 16 months of patient recruit- 
ment, and mortality rates were presented separately for pa- 
tients -<75 years old enrolled uring the whole study and again 
for patients of all ages recruited after October 31, 1991 (Fig. 1 
and 2). Mortality rates for patients -<75 years old did not vary 
throughout the duration of the study. 
Statistical analysis, The relation among patient demo- 
graphics (establishment where patient presented, gender, age), 
cardiac risk factors (hypertension, diabetes, angina before 
myocardial infarction, previous myocardial infarction, current 
smoker, pre-myocardial infarction coronary artery bypass 
grafting, pre-myocardial nfarction percutaneous transluminal 
coronary angioplasty, myocardial infarction characteristics 
[electrocardiographic myocardial infarction type, maximal CK 
rise], post-myocardial infarction course, recurrent angina, 
recurrent myocardial infarction, in-hospital bypass grafting, 
in-hospital coronary angioplasty), acute myocardial infarction 
therapy (thrombolysis, intravenous heparin, intravenous beta- 
adrenergic blocking agents, intravenous nitroglycerin) and 
both in-hospital (Table 1) and postdischarge (Table 2) mortal- 
ity were first evaluated by bivariate analyses. Odds ratios and 
95% confidence intervals for each of these variables were also 
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Figure 2. Evolution of 1-year postdischarge mor- 
tality since 1966. Bars represent ime period of 
patient recruitment for each study. Exclusion 
criteria and limitations are exclusion of patients 
>75 years old (14,19,34); serious illness or Killip 
class >1 (1,14,23,34); exclusion of all patients not 
admitted to a coronary care unit (33). 
calculated. All  variables related to mortal ity with a two-tai led 
p value <0.2 were then included into mult ivariable stepwise 
logistic regression using the maximum l ikel ihood blockwise 
method (demographic  information, cardiac risk factors, myo- 
cardial infarction characteristics, postinfarct ion course and 
acute myocardial  infarction therapy) to determine the inde- 
Table 1. Factors Influencing In-Hospital Mortality 
BivariateAnalyses Multivariable Analyses 
No. (%) Mortality Rate OR p OR p 
Risk Factor of Pts (%) (95% CI) Value (95% CI) Value 
Male* 2,280 (72) 7.7 
Female 898 (28) 15.7 2.23 (1.76-2.82) < 0.001 1.57 (1.18-2.09) 
Age (vs. -< 50 yr)* 562 (18) 3.0 < 0.001 
> 50 to -< 60 783 (25) 5.6 1.92 (1.09-3.40) 1.81 (1.48-2.21) 
> 60 to -< 70 1,090 (34) 9.8 3.49 (2.07-5.88) 2.62 (1.92-3.58) 
> 70 to -< 75 482 (15) 15.8 5.98 (3.48-10.28) 3.95 (2.49-6.27) 
> 75 261 (8) 27.6 12.4 (7.13-21.57) 7.77 (3.83-15.77) 
Hypertension 1,210 (38) 11.3 1.45 (1.14-1.85) 0.002 
Diabetes 665 (21) 16.4 2.34 (1.82-3.02) < 0.001 1.71 (1.27-2.32) 
Angina before MI 1,725 (55) 11.8 1.82 (1.41-2.34) < 0.001 1.44 (1.04-2.00) 
Previous MI 922 (29) 13.8 1.86 (1.46-2.36) < 0.001 1.45 (1.06-1.99) 
Active smoker 1,170 (37) 6.1 0.57 (0.43-0.75) < 0.001 
Premyocardial CABG 339 (11) 11.2 1.14 (0.79-1.64) 0.471 
Premyocardial PTCA 208 (7) 12.0 1.22 (0.78-1.89) 0.384 
MI type (vs. non-Q wave)* 1,381 (43) 9.0 < 0.001 
Anterior Q wave 694 (22) 13.8 1.64 (1.24-2.18) 
Nonanterior O wave 1,103 (35) 8.7 0.97 (0.73-1.28) 
Max (CK vs. -> 11 to 16 times upper limit)* 750 (24) 12.1 0.012 
-< 2.75 792 (25) 8.5 0.64 (0.46-0.90) 0.31 (0.21-0.47) 
2.%-5.65 846 (27) 7.5 0.60 (0.42-0.84) 0.37 (0.25-0.55) 
5.96-11.15 763 (24) 9.2 0.74 (0.53-1.03) 0.58 (0.40-0.85) 
Recurrent angina 899 (29) 9.3 1.07 (0.82-1.39) 0.635 
Recurrent MI 129 (4) 38.0 6.73 (4.63-9.80) < 0.001 8.16 (5.22-12.75) 
Thrombolysis 1,367 (43) 6.9 0.54 (0.42-0.69) < 0.001 0.57 (0.41-0.78) 
IV beta-blockers 596 (19) 7.7 0.72 (0.52-1.00) 0.05 
IV nitroglycerin 2,428 (77) 8.9 0.65 (0.50-0.84) 0.001 
IV heparin 2,561 (81) 8.0 0.40 (0.31-0.51) < 0.001 
0.002 
< 0.001 
NI 
0.001 
0.027 
0.02 
NI 
NI 
NI 
NI 
< 0.001 
NI 
< 0.001 
< 0.001 
NI 
NI 
NI 
*Category against which others are compared. CABG = coronary artery bypass grafting; CI = confidence interval; CK = creatine kinase; IV = intravenous; Max = 
maximal; MI = myocardial infarction; NI = variable not included in the final model; OR = odds ratio; PTCA = percutaneous coronary angioplasty; Pts = patients. 
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Table 2. Factors Influencing One-Year Postdischarge Mortality 
Bivariate Analyses Multivariable Analyses 
No. (%) Mortality OR p OR p 
Risk Factor of Pts (%) (95% CI) Value (95% CI) Value 
Institution NA NA 
Male* 2,105 (74) 5.7 
Female 757 (26) 6.6 1.16 (0.82-1.63) 
Aged (vs. -< 50 yr)* 545 (19) 3.9 
> 50 to -< 60 739 (26) 4.3 1.14 (0.65-1.99) 
> 60 to -< 70 982 (34) 6.3 1.68 (1.01-2.79) 
> 70 to -< 75 406 (14) 6.7 1.77 (0.99-3.18) 
> 75 187 (7) 15.5 4.59 (2.55-8.27) 
Hypertension 1,072 (38) 8.1 1.81 (1.33-2.47) 
Diabetes 555 (19) 10.8 2.40 (1.73-3.33) 
Angina before MI 1,520 (53) 7.8 2.07 (1.48-2.90) 
Previous MI 794 (28) 10.3 2.56 (1.87-3.50) 
Pre-MI CABG 301 (11) 13.0 2.73 (1.87-3.99) 
MI type (vs. non-Q wave)* 1,257 (44) 7.6 
Anterior Q wave 598 (2l) 5.5 0.70 (0.47-1.06) 
Nonanterior Q wave 1,006 (35) 4.2 0.53 (0.36-0.76) 
Killip class (vs. 1)* 1,975 (69) 3.8 
2 667 (23) 8.4 2.29 (1.60-3.28) 
3 or 4 217 (8) 18.0 5.48 (3.62-8.30) 
In-hospital CABG 219 (8) 3.65 0.57 (0.28-1.18) 
In-hospital post-MI PTCA 576 (20) 2.95 0.42 (0.25-0.70) 
Thrombolysis 1,273 (45) 3.77 0.46 (0.33-0.65) 
IV beta-blockers 550 (19) 3.82 0.57 (0.36-0.91) 
IV heparin 2,355 (83) 5.56 0.67 (0.46-0.97) 
0.006 
0.402 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
0.003 
< 0.001 
0.132 
0.001 
< 0.001 
0.018 
0.032 
NA 
0.78 (0.44-1.40) 
0.91 (0.53-1.56) 
0.88 (0.47-1.63) 
1.91 (1.01-3.64) 
1.42 (1.02-1.99) 
1.71 (1.19-2.45) 
1.46 (1.02-2.09) 
2.03 (1.31-3.14) 
2.10 (1.41-3.11) 
3.41 (2.14-5.43) 
0.48 (0.23-1.00) 
0.50 (0.29-0.85) 
0.57 (0.40-0.83) 
0.037 
NI 
0.026 
0.037 
0.004 
NI 
0.038 
0.002 
NI 
< 0.001 
0.051 
0.011 
0.004 
NI 
NI 
*Category against which others are compared. NA = not applicable; other abbreviations as in Table 1. 
pendent relation of these variables with all-cause mortality. 
The 45 patients with incomplete data were excluded from 
the multivariable analyses. The multivariable analyses relat- 
ing to the postdischarge period also included Killip class 
because this variable has been found useful in previous 
analyses, has no associated costs and is easily obtainable in 
all patients. Because in-hospital bypass grafting, coronary 
angioplasty, left ventricular ejection fraction and Holter 
monitoring were most frequently performed a few days 
postinfarction and were thus reserved for patients who had 
survived the first few critical postinfarction days, these four 
variables were excluded from multivariable analyses of 
in-hospital mortality. Prevalence ratios were used to assess 
differences in clinical and laboratory values between pa- 
tients who had complete follow-up or vital status follow-up 
only. Separate bivariate and multivariable analyses to assess 
the relationship of left ventricular ejection fraction and 
premature ventricular contraction frequency with postdis- 
charge mortality were done considering only those patients 
having had these tests. A chi-square analysis was used to 
assess differences in survival according to left ventricular 
ejection fraction and premature ventricular contraction 
frequency categories between patients in the Multicenter 
Post-Infarction Research Group (MPRG) (14) and the 
present study (Fig. 3). 
Resu l ts  
In-hospital and postdischarge mortality. In-hospital (in- 
cluding emergency room deaths) and 1-year postdischarge 
mortality rates were relatively low for patients of all ages 
(November 1, 1991 to end), 9.9% and 7.1%, respectively, and 
even lower for patients -<75 years of age, 8.4% and 5.3%, 
respectively. When considered along with other studies (Fig. 1 
and 2), the results of CAMI are consistent with a trend toward 
reduced in-hospital and postdischarge mortality. 
Factors associated with in-hospital mortality. By bivariate 
analyses, the variables associated with in-hospital mortality are 
illustrated in Table 1. When factors influencing in-hospital 
mortality were considered together in multivariate analyses, 
only female gender, advancing age, diabetes, angina before 
myocardial infarction, previous myocardial infarction, maximal 
CK rise and recurrent myocardial infarction were correlated 
with mortality, and thrombolysis use was inversely correlated 
with mortality (Table 1). 
Factors associated with 1-year postdischarge mortality. By 
bivariate analyses, the variables associated with 1-year postdis- 
charge mortality are illustrated in Table 2. Female gender 
(odds ratio [OR] 1.16, 95% confidence interval [CI] 0.82 to 
1.63, p = 0.40) was not associated with 1-year postdischarge 
mortality. When factors influencing 1-year postdischarge mor- 
tality are considered together in multivariate analyses, only 
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Figure 3. Comparison of cardiac mortality (11) between the multi- 
center postinfarction research group (MPRG) (11) and present study 
(CAMI) according to left ventricular ejection fraction and premature 
ventricular contraction category, p = MPRG versus CAMI study; 
numbers within or above columns = number of patients in that group. 
advancing age, a history of hypertension, diabetes, previous 
myocardial infarction, preinfarction coronary artery bypass 
grafting and Killip class were correlated with mortality, and 
in-hospital coronary artery bypass grafting or percutaneous 
coronary angioplasty and thrombolysis use were inversely 
correlated with mortality (Table 2). The institution where the 
myocardial infarction occurred also remained significantly 
related to survival; however, when left ventricular ejection 
fraction was added to the model, the influence of the institu- 
tion disappeared (p = 0.44), suggesting that institutional 
differences were the result of differences in ventricular func- 
tion. Although left ventricular ejection fraction significantly 
altered mortality, its addition to the model did not significantly 
alter the association between mortality and any of the other 
variables. 
Left ventricular ejection fraction and Holter monitoring. 
The 1-year postdischarge mortality of the 2,192 patients who 
agreed to a complete follow-up was less than that of the 670 
patients who agreed to vital status follow-up only (5.4% vs. 
7.9%, p = 0.015). However, when patients dying of noncardio- 
vascular causes are excluded from analyses, mortality of pa- 
tients with both complete and vital status follow-up were more 
similar (4.73% vs. 5.96%, p = 0.21), suggesting that results of 
Table 3. Causes of Death 
In-Hospital Postdischarge 
(predischarge) (1-yr follow-up) 
(n - 316) (n = 171) 
Cardiovascular 314 (99) 135 (79) 
Recurrent MI 34 (11) 36 (21) 
Low output 171 (54) 28 (16) 
Presumed arrhythmia 26 (8) 53 (31) 
Procedural 21 (7) 14 (8) 
Other 62 (20) 3 (2) 
Noneardiovascular 2 (1) 29 (17) 
Cancer 16 (9) 
Insufficient information 0 7 
MI = myocardial infarction. 
risk stratification of patients with a complete follow-up were 
representative of those of all patients. 
As was found in the MPRG study (14), in the CAMI study, 
1-year postdischarge cardiac mortality increased progressively 
with decreasing left ventricular ejection fraction (Fig. 3). 
However, for a given ejection fraction, cardiac mortality was 
lower in the CAMI study (p = 0.008). When added to our 
multivariable model for 1-year postdischarge total mortality, 
left ventricular ejection fraction was the most powerful predic- 
tor (inversely) of mortality (Wald chi-square 44.7, p < 0.001). 
The odds ratio for patients with a left ventricular ejection 
fraction -<30% was 9.48 (95% CI 4.6 to 19.7, p < 0.001); for a 
left ventricular ejection fraction >30% but -<40%, the odds 
ratio was 2.94 (95% CI 1.4 to 6.15, p = 0.004); and for a left 
ventricular ejection fraction >40% but -<50%, the odds ratio 
was 1.41 (95% CI 0.65 to 3.06, p = 0.39) compared with 
patients with a left ventricular ejection fraction >50%. 
As found in the MPRG study (14), in the CAMI study, 
1-year postdischarge cardiac mortality increased progressively 
with increasing premature ventricular contractions per hour 
(Figure 3). However, as with left ventricular ejection fraction, 
for a given premature ventricular contraction category, cardiac 
mortality in the CAMI study was lower (p = 0.003), the 
decrease being most marked in patients with 10 to 30 prema- 
ture ventricular contractions/la (Fig. 3). Also, the number of 
patients with frequent premature ventricular contractions 
(->10/la) was somewhat lower, 16% vs. 20% (p = 0.007). 
However, when added to our multivariable model for 1-year 
postdischarge total mortality (with left ventricular ejection 
fraction excluded so as not to lose the 17% of patients without 
left ventricular ejection fraction data), premature ventricular 
contraction frequency was no longer predictive of mortality. 
Cause of death. The overwhelming majority of deaths were 
of cardiovascular causes (Table 3). Low output was by far the 
most common mode of in-hospital death (54%). Presumed 
arrhythmic death was not a very frequent cause of in-hospital 
mortality (8%) but was the most common cause of first-year 
postdischarge mortality (31%). Nevertheless, because rela- 
tively few patients died during the first year after hospital 
discharge, only 1.9% of all discharged patients died a pre- 
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sumed arrhythmic death. A relatively high number of patients 
died of noncardiovascular causes (17% of deaths) during the 
first postdischarge y ar. 
Recurrent myocardial infarction: effect of age. In-hospital 
recurrent myocardial infarction rate was relatively low in 
patients -<75 years old (3.9%). Reinfarction rate was some- 
what higher in patients >75 years old (6.3%, p < 0.001). 
One-year postdischarge myocardial infarction rate was also 
relatively low (6.1% for patients of all ages [November 1991 to 
December 1992]). However, again, the 1-year postdischarge 
recurrent myocardial infarction rate was much higher in pa- 
tients >75 years old than patients -<75 years old (11.2% vs. 
5.7%, p < 0.001), such that from the time of arrival to hospital 
to 1 year postinfarction, patients >75 years old had nearly 
twice the risk of reinfarction (17.4% vs. 9.6%, p < 0.001) than 
younger patients. Despite this greater risk of reinfarction, 
patients >75 years old had fewer in-hospital revascularization 
procedures (13% vs. 27%, p < 0.001). 
Discharge medications. Coronary arteriography or exer- 
cise stress testing was performed in 82% of patients before 
hospital discharge. Thirty percent had exercise stress testing 
only, 26% had coronary angiography only, and 26% had both. 
Patients were discharged with beta-blockers (61%), aspirin 
(86%), anticoagulant agents (7%), angiotensin-converting e - 
zyme inhibitors (24%), calcium antagonists (34%), antiar- 
rhythmic agents (2%) and digoxin (10%). The use of calcium 
antagonists was greater (45% vs. 21%, p < 0.001) in patients 
with non-Q wave infarctions or who had a postinfarction 
coronary angioplasty, and angiotensin-converting e zyme in- 
hibitors were used more frequently in patients with Killip class 
>1 or anterior Q wave myocardial infarctions (42% vs. 12%, 
p < 0.001). 
Discuss ion  
This multicenter study documents he lowest 1-year postin- 
farction mortality ever reported in a large unselected patient 
population. The mortality rate for patients -<75 years old was 
13.7%, and that for patients of all ages was 17%. Figure 1 
shows that the results of CAMI are consistent with an ever- 
decreasing in-hospital mortality rate that is now <50% of what 
it was 25 years ago. Figure 2 demonstrates a similar but 
somewhat smaller improvement in 1-year postdischarge mor- 
tality. When compared to the MPRG study (14) of 10 years ago 
(Fig. 3), it appears that the improvement in postdischarge 
survival has occurred over the whole spectrum of postinfarc- 
tion patients, whether their ventricular function is good or 
poor and whether they have frequent premature ventricular 
contractions or not. The reasons for these changes are complex 
and likely include changes in investigation and treatment of 
patients, changes in life-style and perhaps changes in the 
characteristics of patients having an acute myocardial infarc- 
tion. The results of this study have major implications on the 
design of strategies to reduce mortality further after myocar- 
dial infarction. 
Reinfarction and revascularization. The in-hospital rein- 
farction rate identified in this study (5.3%) is equivalent to or 
slightly higher than that reported recently (16) and somewhat 
lower than those reported 10 years ago (6% to 9%) (34,35). 
Postdischarge reinfarction rate, at 6.1%, was similar to or 
lower than those reported by other broad-based studies done 
10 years ago (1,35) but somewhat higher than that reported by 
studies restricted to patients receiving thrombolytic therapy 
(5,12,36). In this study, the rather frequent use of pharmaco- 
logic interventions such as aspirin (3), beta-blockers (2) and 
angiotensin-converting e zyme inhibitors (6) at hospital dis- 
charge, along with the judicious use of revascularization pro- 
cedures, may have helped account for the relatively low 
reinfarction rate and thus also contributed to improved sur- 
vival. Considering the results of the Cardiac Arrhythmia 
Suppression Trial (CAST) (15), the infrequent use of antiar- 
rhythmic agents (2%) in this study may also have contributed 
to improved survival, particularly to the improved survival of 
patients with ->10 premature ventricular contractions/h. 
The use of in-hospital coronary artery bypass grafting in this 
study was similar to that of hospitals without on-site cardiac 
catheterization facilities in the Myocardial Infarction Triage 
and Intervention (MITI) study (7.7% vs. 8.5%) (16). The use 
of percutaneous coronary angioplasty was intermediate be- 
tween that reported for a hospital with and without cardiac 
catheterization facilities in MITI. Nevertheless, the use of 
in-hospital revascularization procedures in this study is signif- 
icantly greater than that reported 10 to 15 years ago (21,35), 
before the widespread use of angioplasty, and may have 
contributed to the improved postdischarge prognosis of pa- 
tients in this study. 
Patient profile and risk stratification. The profile of pa- 
tients admitted for an acute myocardial infarction also appears 
to have changed. In this study, the majority of patients had a 
prior history of coronary artery disease, and a large number of 
patients had a non-Q wave myocardial infarction. Previous 
reports have been divided (37,38) as to whether the proportion 
of patients having a non-Q wave myocardial infarction is 
increasing, but, except for one study (38), this proportion has 
varied from 20% to 30%, a number much smaller than the 44% 
reported here. Potential explanations for this finding include 
better collateral circulation as a result of chronic coronary 
artery disease, abortion of otherwise Q wave infarctions as a 
result of the use of thrombolytic therapy, the widespread use of 
aspirin, and a lower proportion of missed non-Q wave infarc- 
tions as a result of the more widespread and routine use of 
cardiac enzymes. By recta-analyses (39), patients with non-Q 
wave infarction have been shown to have a higher postdis- 
charge mortality; however, when other clinical and laboratory 
variables were considered along with myocardial infarction 
type, the increased risk associated with non-Q wave myocardial 
infarction disappeared (40). 
Consistent with some (5,43-46) but not all (47-51) previous 
reports, female gender was associated with a 2.23-fold increase 
in in-hospital mortality, and, even after correcting for other 
important risk factors, female gender continued to be associ- 
1126 ROULEAU ET AL. JACC Vol. 27, No. 5 
MYOCARDIAL INFARCTION IN THE 1990s April 1996:1119-27 
ated with a 1.57-fold increased risk. Consistent with previous 
reports (47,48), postdischarge risk was independent ofgender, 
whether by bivariate or multivariate analyses. Why female 
gender is associated with an increased in-hospital but not 
postdischarge risk is uncertain but somewhat reassuring as to 
our predischarge risk stratification in female patients. 
As in previous studies, age was a powerful independent 
predictor of in-hospital mortality, particularly for patients >75 
years old (12,18,28,31,34,52). However, as opposed to previous 
studies (18,34), age up to 75 years carried no postdischarge 
independent risk, and, even age >75 years carried only a 
twofold risk. The reasons for this decrease in age-related risk 
are uncertain but may at least partially be the result of the 
inclusion of ill patients of all ages in this analysis, and the 
inclusion of more prognostic variables, such as myocardial 
reinfarction, in our model. Older patients had a greater isk of 
both in-hospital and postdischarge r infarction, a finding dif- 
ferent from all but one previous report (12,34,35). Why this 
occurred is uncertain, but it may be related to more diffuse 
coronary artery disease in older patients. Another possibility is 
less aggressive investigation and treatment of residual isch- 
emia: older patients had fewer evascularization procedures in
this study. In any case, it appears from this study that a higher 
reinfarction rate may play a role in the documented increase in 
age-related postinfarction mortality. 
Causes of death. The cause of death in this study also 
varies somewhat from what has been previously reported. 
Although the great number of patients (>50%) dying in 
hospital of low output is compatible with other recent reports 
(22), it appears that postdischarge death from presumed 
arrhythmic causes is becoming less frequent. In this study, only 
1.9% of patients died of presumed arrhythmic auses during 
the first postdischarge y ar. This, combined with the lack of 
independent predictive value of predischarge premature ven- 
tricular contractions on Holter monitoring, suggests that alter- 
native strategies are needed to identify patients at high risk of 
dying suddenly. 
Study limitations. This study has some limitations: 1) The 
evaluation of predischarge risk did not include an evaluation of 
coronary anatomy (53) or whether predischarge exercise test- 
ing was performed (50) two variables known to be predictive of 
subsequent mortality. This occurred because practice patterns 
differed markedly from one physician to another and from one 
hospital to another. However, prehospital discharge risk strat- 
ification was done by exercise testing or coronary arteriography 
in 82% of patients, which, according to the results of phase liB 
of the Thrombolysis In Myocardial Infarction Trial (13), 
should have identified patients at risk of subsequent ischemic 
episodes and thus in need of coronary revascularization. The 
low postdischarge mortality and reinfarction rate of our study 
support his assumption. 
2) Although vital status was assessed in all patients, left 
ventricular ejection fraction, Holter monitoring and follow-up 
for postdischarge cardiovascular events could only be done in 
patients who agreed to a full workup and follow-up. Because 
mortality was higher in patients with vital status follow-up only, 
some bias may have been introduced. However, when patients 
dying from noncardiovascular causes were excluded from 
analyses, the profile and survival of patients with only vital 
status follow-up resembled that of patients with complete 
follow-up, suggesting that differences in mortality were largely 
the result of noncardiovascular causes. 
3) Some care must be exercised when extrapolating results 
of this study to other countries and settings. Although disputed 
(54), one recent report (55) suggests that postinfarction mor- 
tality is lower in the United States than in Canada. If postin- 
farction mortality is lower in the United States, the results of 
CAMI may overestimate he actual mortality in the United 
States. Also, although no differences in mortality were noted 
between centers with and without invasive catheterization 
facilities in this or previous tudies (16), and no difference in 
mortality according to academic status could be documented in 
this study, small differences in survival related to the profile of 
a given center cannot be ruled out. 
Finally, although vital status at 1 year was obtained in all but 
3 patients, incomplete baseline data were obtained in 45 
patients, 25 of whom died during the first few hours of their 
myocardial infarction. Thus, our in-hospital model is limited in 
its ability to predict early in-hospital mortality. 
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